Beta-cyclodextrin/salicylic acid complex in pads for wart treatment
A novel product labeled as “SottSunFeli Maximum strength wart remover patches” containing beta-cyclodextrin and 30% salicylic acid as active ingredient
Author: István Puskás
research chemist
A β-cyclodextrin polymer reduces cholesterol accumulation and mitigates autophagy dysfunction in vitro and in a Niemann–Pick Type C animal model
Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are both characterised by cognitive decline and neurological impairment. In each
Fresh Feet with Smarter Science
If you’re tired of sweaty, smelly shoes and want a fresh-feeling stride all day long, the Oh Happy Days Fresh
BCD in starch-based composite active sheets for the preservation and packaging of blueberry fresh fruit
After embedding β-cyclodextrin/preservative complexes into the packaging films for blueberry preservation e.g. thymol [1], curcumin [2], Vitamin C [3], resveratrol
A Cyclodextrin Containing Japanese Pet Cleaning Glove 🐾
Meet this wonderful Japanese pet-cleaning glove, infused with the power of cyclodextrin, the same smart ingredient often used in high-end
SQ Innovation: FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients
This second-generation delivery device provides a cost-efficient alternative to in-hospital treatment. Lasix® ONYU represents the most recent FDA-approved formulation incorporating
7 of 9 patients showed stabilization or improvement: preliminary data from ongoing Phase 3 TransportNPC™ clinical trial
Rafael Holdings, Inc. announced that data from Cyclo Therapeutics’ Phase 3 TransportNPC™ open-label, single-arm sub-study evaluating Trappsol® Cyclo™ (hydroxypropyl-beta-cyclodextrin) for Niemann-Pick
A bagel mimicking the shape of cyclodextrin and also containing cyclodextrin
It is a delightful coincidence that the product’s shape reflects the molecular structure of its key ingredient. In this short
α-CD Derivatives: Low Efficacy and Ototoxicity in NPC Models
HP-β-CD is currently under clinical investigation for treating Niemann-Pick disease type C (NPC), but its ototoxicity remains problematic. It was
β-Cyclodextrin/Epichlorohydrin Crosspolymer: a New Cosmetic Ingredient in China
According to data from China’s National Medical Products Administration (NMPA), Shandong Binzhou Zhiyuan Biotechnology Co., Ltd. successfully filed β-Cyclodextrin/Epichlorohydrin Crosspolymer